Infectious disease update

Dermatologic Clinics

Volumn 19, Issue 4, 2001, Pages 749-756

  Manders, Steven M ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA HEMOLYTIC STREPTOCOCCUS; DESQUAMATION; EHRLICHIOSIS; ERYTHEMA; GRAM NEGATIVE INFECTION; INFECTION; NECROTIZING FASCIITIS; PENICILLIUM MARNEFFEI; PRIORITY JOURNAL; REVIEW; STAPHYLOCOCCUS; STREPTOCOCCUS; TOXIC SHOCK SYNDROME;

EID: 0034753607     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8635(05)70313-2     Document Type: Article

References (102)

1. Retroviral superantigens
2. Toxic shock syndrome due to percutaneous Kirschner wires
3. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses
4. Penicillosis marneffei infection in AIDS
5. Group A beta hemolytic streptococcal necrotizing fasciitis
6. The reemergence of serious group A streptococcal infections and acute rheumatic fever
7. Aerobic and anaerobic microbiology of necrotizing fasciitis in children
8. Cutaneous ?? tions of non-01 Vibrio cholerae septicemia wit?? troenteritis and meningitis
9. Genetic and phenotypic diversity among isolates of Streptococcus pyogenes from invasive infections
10. Clinical aspects and spectrum of illness of toxic shock syndrome: Overview
11. Clinical manifestations of toxic shock syndrome
12. An outbreak of invasive group A streptococcal disease associated with high carriage rates of the invasive clone among school-aged children
13. A recalcitrant, erythematous, desquamating disorder associated with toxin-producing staphylococci in patients with AIDS
14. Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes
15. Apparent lower rates of streptococcal toxic shock syndrome and lower mortality in children with invasive group A streptococcal infections compared with adults
16. Invasive group A streptococcal infections in Ontario, Canada
17. Superantigens interact with MHC class II molecules outside of the antigen groove
18. Severe invasive group A streptococcal infections in Ontario, Canada: 1987- 1991
19. Human ehrhchiosis: Newly recognized infections transmitted by ticks
20. The effect of topical antimicrobial agents on the production of toxic shock syndrome toxin- 1
21. Toxic shock syndrome-associated staphylococcal and streptococcal pyrogenic toxins are potent inducers of tumor necrosis production
22. Toxic shock syndrome associated with Staphylococcus aureus sinusitis in children
23. Toxic shock syndrome as the AIDS-defining diagnosis
24. High affinity binding of staphylococcal enterotoxins A and B to HLA-DR
25. Superantigens activate HIV- 1 gene expression in monocytic cells
26. Staphylococcal superantigens activate HIV- 1 replication in naturally infected monocytes
27. Streptococcal toxic shock syndrome: Synthesis of tumor necrosis factor and interleukin- 1 by monocytes stimulated with pyrogenic exotoxin A and streptolysin O
28. Toxic shock syndrome in the United States: Surveillance update, 1979- 1996
29. Molecular analysis of pyrogenic exotoxins from Streptococcus pyogenes isolates associated with toxic shock-like syndrome
30. Superantigens: Mechanism of T-cell stimulation and role in immune responses
31. Human ehrlichiosis
32. The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome
33. Aspects of pathogenesis of serious group A streptococcal infections in Sweden, 1988-1989
34. The emergence of another tickborne infection in the 12-town area around Lyme, Connecticut: Human granulocytic ehrlichiosis
35. Induction by toxic-shock-syndrome toxin-1 of a circulating tumor necrosis factor-like substance in rabbits and of immunoreactive tumor necrosis factor and interleukin- 1 from human mononuclear cells
36. Superantigens: Structure and relevance to human disease
37. Toxic shock syndrome toxin 1 as an inducer of human tumor necrosis factors and gamma-interferon
38. Severe streptococcal infections in historical perspective
39. Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome-A comparative observational study
40. Primary septicemia caused by Vibrio cholerae non-01 acquired on Cape Cod, Massachusetts
41. Necrotizing fasciitis
42. Superantigens and their potential role in human disease
43. Current knowledge of type-specific M antigens of group A streptococci
44. Toxic shock syndrome: Clinical, laboratory, and pathologic findings in nine fatal cases
45. Lower extremity manifestations of Vibrio vulnificus infection
46. The role of superantigens in skin disease
47. Disseminated Penicillium marneffei infection with cutaneous lesions in an HIV-positive patient
48. Congenital streptococcal toxic shock syndrome with absence of antibodies against streptococcal pyrogenic exotoxins
49. Bacterial superantigens induce Vβ-specific T cell receptor internalization
50. Toxic shock syndrome: A newly recognized complication of influenza and influenza-like illness
51. Toxin-mediated streptococcal and staphylococcal disease
52. Recurrent toxin-mediated perineal erythema
53. The staphylococcal enterotoxins and their relatives
54. The human ehrlichioses in the United States
55. Streptococcal toxic shock-like syndrome: Evidence of superantigen activity and its effects on T lymphocyte subsets in vivo
56. Fungal infections in patients with acquired immunodeficiency syndrome
57. A novel superantigen isolated from pathogenic strains of Streptococcus pyogenes with aminoterminal homology to staphylococcal enterotoxins B and C
58. "Flesh-eating bacteria": Return of an old nemesis
59. Human pro- and anti-inflammatory cytokine patterns induced by Streptococcus pyogenes erythrogenic (pyrogenic) exotoxin A and C superantigens
60. Comparative study of cytokine release by human peripheral blood mononuclear cells stimulated with Streptococcus pyogenes superantigenic erythrogenic toxins, heat-killed streptococci, and lipopolysaccharide
61. Streptococcus pyogenes causing toxic-shock-like-syndrome and other invasive disease: Clonal diversity and pyrogenic exotoxin expression
62. Fatal septicemia and bullae caused by non-01 Vibrio cholerae
63. Correlation between serum TNF-α and IL- 6 levels and severity of group A streptococcal infections
64. Production of tumor necrosis factor by human monocytes in response to toxic shock syndrome toxin- 1
65. Group A streptococcal infections of the skin and pharynx
66. Analysis of the interaction site for the self superantigen M1s-1 on T cell receptor Vβ
67. Necrotizing fasciitis
68. Molecular characterization and phylogenetic distribution of the streptococcal superantigen gene (SSA) from Streptococcus pyogenes
69. Nonmenstrual toxic shock syndrome: A review of 130 cases
70. Staphylococcal toxin-mediated syndromes in childhood
71. Superantigens and their role in infectious disease
72. Role of superantigens in human disease
73. Production of staphylococcal pyrogenic exotoxin type C: Influence of physical and chemical factors
74. Molecular structure of staphylococcus and streptococcus superantigens
75. Changing epidemiology of group A streptococcal infection in the USA
76. Nonmenstrual toxic shock syndrome in a young child with human immunodeficiency infection
77. Toxic-shock syndrome in menstruating women: Association with tampon use and Staphylococcus aureus and clinical features in 52 cases
78. Disseminated Penicillium marneffei infection in human immunodeficiency virus-infected children
79. Superantigens: Do they have a role in skin diseases?
80. The acquired immunodeficiency syndrome and nonmenstrual toxic shock syndrome
81. Invasive group A streptococcus infections
82. The toxic shock syndromes
83. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A
84. The nature of rheumatogenic streptococci
85. Necrotizing fasciitis: The changing spectrum
86. Toxic shock syndrome: Are you recognizing its changing presentations?
87. Exanthematous disease induced by toxic shock syndrome toxin I in the early neonatal period
88. Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome
89. Toxic shock syndrome: Scientific uncertainty and the public media
90. Toxic shock syndrome associated with phage-group-I staphylococci
91. Cutaneous Vibrio infections
92. Hemorrhagic bullae associated with Vibrio vulnificus septicemia
93. Toxic shock syndrome after suction lipectomy
94. Severe recalcitrant desquamating disorder associated with fatal recurrent toxic shock syndrome in a patient without AIDS
95. Major histocompatability complex class II-associated peptides determine the binding of the superantigen toxic shock syndrome toxin- 1
96. Acute group G streptococcal myositis associated with streptococcal toxic shock syndrome: Case report and review
97. Toxic shock syndrome after explantation of breast implants: A case report and review of the literature
98. Selective depletion of V beta-bearing T cells in patients with severe invasive group A streptococcal infections and streptococcal toxic shock syndrome
99. Streptococcal toxic shocklike syndrome
100. Streptococcal toxic shock-like syndrome: The importance of surgical intervention
101. The human immunodeficiency virus and nonmenstrual toxic shock syndrome: A female case presentation
102. A new type of mitogenic factor produced by Streptococcus pyogenes